Morphogenetic Designs, and Disease Models in Central Nervous System Organoids DOI Open Access
Minsung Bock, Sung Jun Hong, Songzi Zhang

и другие.

International Journal of Molecular Sciences, Год журнала: 2024, Номер 25(14), С. 7750 - 7750

Опубликована: Июль 15, 2024

Since the emergence of first cerebral organoid (CO) in 2013, advancements have transformed central nervous system (CNS) research. Initial efforts focused on studying morphogenesis COs and creating reproducible models. Numerous methodologies been proposed, enabling design brain to represent specific regions spinal cord structures. CNS organoids now facilitate study a wide range diseases, from infections tumors, which were previously difficult investigate. We summarize major organoids, concerning morphogenetic designs disease examine development fabrication procedures how these enabled generation region-specific highlight application various demonstrating versatility potential models advancing our understanding complex conditions. discuss current challenges field, including issues related reproducibility, scalability, accurate recapitulation vivo environment. provide an outlook prospective studies future directions. This review aims comprehensive overview state-of-the-art research, highlighting key developments, challenges, prospects field.

Язык: Английский

An integrated transcriptomic cell atlas of human neural organoids DOI Creative Commons
Zhisong He, Leander Dony, Jonas Simon Fleck

и другие.

Nature, Год журнала: 2024, Номер 635(8039), С. 690 - 698

Опубликована: Ноя. 20, 2024

Human neural organoids, generated from pluripotent stem cells in vitro, are useful tools to study human brain development, evolution and disease. However, it is unclear which parts of the covered by existing protocols, has been difficult quantitatively assess organoid variation fidelity. Here we integrate 36 single-cell transcriptomic datasets spanning 26 protocols into one integrated cell atlas totalling more than 1.7 million cells1–26. Mapping developing references27–30 shows primary types states that have estimates similarity between counterparts across protocols. We provide a programmatic interface browse query new datasets, showcase power annotate evaluate Finally, show can be used as diverse control cohort compare models disease, identifying genes pathways may underlie pathological mechanisms with models. The will fidelity, characterize perturbed diseased facilitate protocol development. A integrating counterparts, showing potential fidelity

Язык: Английский

Процитировано

23

A molecular and cellular perspective on human brain evolution and tempo DOI
Feline W Lindhout, Fenna M. Krienen, Katherine S. Pollard

и другие.

Nature, Год журнала: 2024, Номер 630(8017), С. 596 - 608

Опубликована: Июнь 19, 2024

Язык: Английский

Процитировано

18

Brain organoid protocols and limitations DOI Creative Commons
Helen Zhao, Gabriel G. Haddad

Frontiers in Cellular Neuroscience, Год журнала: 2024, Номер 18

Опубликована: Март 20, 2024

Stem cell-derived organoid technology is a powerful tool that revolutionizes the field of biomedical research and extends scope our understanding human biology diseases. Brain organoids especially open an opportunity for brain modeling many neurological diseases, which have lagged due to inaccessibility samples lack similarity with other animal models. can be generated through various protocols mimic whole or region-specific. To provide overview technology, we summarize currently available list several factors consider before choosing protocols. We also outline limitations current challenges need solved in future investigation development pathobiology.

Язык: Английский

Процитировано

15

Rigor and reproducibility in human brain organoid research: Where we are and where we need to go DOI Creative Commons
Soraya O. Sandoval, Gerarda Cappuccio, Karina Kruth

и другие.

Stem Cell Reports, Год журнала: 2024, Номер 19(6), С. 796 - 816

Опубликована: Май 16, 2024

Human brain organoid models have emerged as a promising tool for studying human development and function. These preserve genetics recapitulate some aspects of development, while facilitating manipulation in an vitro setting. Despite their potential to transform biology medicine, concerns persist about fidelity. To fully harness potential, it is imperative establish reliable analytic methods, ensuring rigor reproducibility. Here, we review current analytical platforms used characterize forebrain cortical organoids, highlight challenges, propose recommendations future studies achieve greater precision uniformity across laboratories.

Язык: Английский

Процитировано

14

Modelling human brain development and disease with organoids DOI
Marcella Birtele, Madeline A. Lancaster, Giorgia Quadrato

и другие.

Nature Reviews Molecular Cell Biology, Год журнала: 2024, Номер unknown

Опубликована: Дек. 12, 2024

Язык: Английский

Процитировано

9

ARSACS: Clinical Features, Pathophysiology and iPS-Derived Models DOI

Ikhlass Haj Salem,

Mathieu Blais,

Valeria Zuluaga-Sanchez

и другие.

The Cerebellum, Год журнала: 2025, Номер 24(1)

Опубликована: Янв. 3, 2025

Язык: Английский

Процитировано

1

Generating human neural diversity with a multiplexed morphogen screen in organoids DOI
Neal D. Amin,

Kevin W. Kelley,

Konstantin Kaganovsky

и другие.

Cell stem cell, Год журнала: 2024, Номер 31(12), С. 1831 - 1846.e9

Опубликована: Дек. 1, 2024

Язык: Английский

Процитировано

8

Unravelling the Cerebellar Involvement in Autism Spectrum Disorders: Insights into Genetic Mechanisms and Developmental Pathways DOI Creative Commons
Marika Guerra, Vanessa Medici, Gina La Sala

и другие.

Cells, Год журнала: 2024, Номер 13(14), С. 1176 - 1176

Опубликована: Июль 10, 2024

Autism spectrum disorders (ASDs) are complex neurodevelopmental conditions characterized by deficits in social interaction and communication, as well repetitive behaviors. Although the etiology of ASD is multifactorial, with both genetic environmental factors contributing to its development, a strong basis widely recognized. Recent research has identified numerous mutations genomic rearrangements associated ASD-characterizing genes involved brain development. Alterations developmental programs particularly harmful during critical periods Notably, studies have indicated that disruptions occurring second trimester pregnancy affect cortical while disturbances perinatal early postnatal period cerebellar The defects must be viewed context role cerebellum cognitive processes, which now established. present review emphasizes complexity neuropathological mechanisms underlying aims provide insights into involvement disorder, focusing on recent advances molecular landscape governing development humans. Furthermore, we highlight when neurons ASD-associated may play cortico–cerebellar circuits. Finally, discuss improvements protocols for generating organoids recapitulate long maturation this organ. These models, if generated from patient-induced pluripotent stem cells (iPSC), could valuable approach elucidate contribution defective pathology inform diagnostic therapeutic strategies.

Язык: Английский

Процитировано

5

Human organoid model of pontocerebellar hypoplasia 2a recapitulates brain region-specific size differences DOI Creative Commons
Theresa Kagermeier, Stefan Hauser, Kseniia Sarieva

и другие.

Disease Models & Mechanisms, Год журнала: 2024, Номер 17(7)

Опубликована: Июль 1, 2024

ABSTRACT Pontocerebellar hypoplasia type 2a (PCH2a) is an ultra-rare, autosomal recessive pediatric disorder with limited treatment options. Its anatomical hallmark of the cerebellum and pons accompanied by progressive microcephaly. A homozygous founder variant in TSEN54, which encodes a tRNA splicing endonuclease (TSEN) complex subunit, causal. The pathological mechanism PCH2a remains unknown due to lack model system. Therefore, we developed human models using regionalized neural organoids. We generated induced pluripotent stem cell (iPSC) lines from three males genetically confirmed subsequently differentiated cerebellar neocortical Mirroring clinical neuroimaging findings, organoids were reduced size compared controls starting early differentiation. Neocortical demonstrated milder growth deficits. Although did not upregulate apoptosis, their zones showed altered proliferation kinetics, increased at day 30 50 controls. In summary, PCH2a, providing foundation for deciphering brain region-specific disease mechanisms. Our first analyses suggest neurodevelopmental aspect PCH2a.

Язык: Английский

Процитировано

4

Advances in physiological and clinical relevance of hiPSC-derived brain models for precision medicine pipelines DOI Creative Commons

Negin Imani Farahani,

Lisa Lin,

Shama Nazir

и другие.

Frontiers in Cellular Neuroscience, Год журнала: 2025, Номер 18

Опубликована: Янв. 6, 2025

Precision, or personalized, medicine aims to stratify patients based on variable pathogenic signatures optimize the effectiveness of disease prevention and treatment. This approach is favorable in context brain disorders, which are often heterogeneous their pathophysiological features, patterns progression treatment response, resulting limited therapeutic standard-of-care. Here we highlight transformative role that human induced pluripotent stem cell (hiPSC)-derived neural models poised play advancing precision for particularly emerging innovations improve relevance hiPSC physiology. hiPSCs derived from accessible patient somatic cells can produce various types tissues; current efforts increase complexity these models, incorporating region-specific tissues non-neural microenvironment, providing increasingly relevant insights into human-specific neurobiology. Continued advances tissue engineering combined with genomics, high-throughput screening imaging strengthen physiological thus ability uncover mechanisms, vulnerabilities, fluid-based biomarkers will have real impact neurological True understanding, however, necessitates integration hiPSC-neural biophysical data, including quantitative neuroimaging representations. We discuss recent cellular neuroscience provide direct connections through generative AI modeling. Our focus great potential synergy between pave way personalized becoming a viable option suffering neuropathologies, rare epileptic neurodegenerative disorders.

Язык: Английский

Процитировано

0